{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:42:52Z","timestamp":1784641372156,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Tumor-induced osteomalacia is a rare, acquired paraneoplastic syndrome, including hypophosphatemia, high serum alkaline phosphatase, reduced active vitamin D, suboptimal bone mineral density, bone pain, fragility fractures, and muscle weakness.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report a case of 74\u2013year\u2013old male of mixed ancestry with hypophosphatemia resistant to treatment despite optimal compliance, associated with profound reduction of bone mineral density and multiple nontraumatic fractures, including bilateral rib fractures, lower-thoracic (T11, T12) vertebrae, and two fractures involving the surgical and anatomical neck of the right humerus. We discuss an approach to identifying the underlying cause of hypophosphatemia associated with fragility fractures, and options for management of this rare condition.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Although rare, tumor-induced osteomalacia can be diagnosed if a logical stepwise approach is implemented. Surgery could be curative if the tumor is properly located and is resectable.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-021-03220-7","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:02:42Z","timestamp":1641945762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tumor-induced osteomalacia: a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"Khalid","family":"Aligail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel A.","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Louis","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"issue":"1","key":"3220_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.44","volume":"3","author":"S Minisola","year":"2017","unstructured":"Minisola S, et\u00a0al. Tumour-induced osteomalacia. Nat Rev Dis Primers. 2017;3(1):1\u201315.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"3220_CR2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/art.23278","volume":"58","author":"EM Lewiecki","year":"2008","unstructured":"Lewiecki EM, Urig EJ Jr, Williams RC Jr. Tumor-induced osteomalacia: lessons learned. Arthrit Rheum. 2008;58(3):773\u20137.","journal-title":"Arthrit Rheum"},{"issue":"6","key":"3220_CR3","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.berh.2003.09.004","volume":"17","author":"AJ Reginato","year":"2003","unstructured":"Reginato AJ, Coquia JA. Musculoskeletal manifestations of osteomalacia and rickets. Best Pract Res Clin Rheumatol. 2003;17(6):1063\u201380.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"3220_CR4","doi-asserted-by":"publisher","first-page":"938","DOI":"10.4103\/1319-2442.118087","volume":"24","author":"MA Hazzazi","year":"2013","unstructured":"Hazzazi MA, et\u00a0al. Clinical presentation and etiology of osteomalacia\/rickets in adolescents. Saudi J Kidney Dis Transplant. 2013;24(5):938.","journal-title":"Saudi J Kidney Dis Transplant"},{"issue":"11","key":"3220_CR5","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1007\/s00467-012-2175-z","volume":"27","author":"MGM Penido","year":"2012","unstructured":"Penido MGM, Alon US. Phosphate homeostasis and its role in bone health. Pediatr Nephrol. 2012;27(11):2039\u201348.","journal-title":"Pediatr Nephrol"},{"issue":"6475","key":"3220_CR6","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1136\/bmj.290.6475.1146-c","volume":"290","author":"B Thalayasingam","year":"1985","unstructured":"Thalayasingam B. Coeliac disease as a cause of osteomalacia and rickets in the Asian immigrant population. Br Med J (Clin Res Ed). 1985;290(6475):1146.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"4214","key":"3220_CR7","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1126\/science.1188357","volume":"190","author":"MR Hughes","year":"1975","unstructured":"Hughes MR, et\u00a0al. Regulation of serum 1alpha, 25-dihydroxyvitamin D3 by calcium and phosphate in the rat. Science. 1975;190(4214):578\u201380.","journal-title":"Science"},{"key":"3220_CR8","unstructured":"Hutchison FN, Bell NH. Osteomalacia and rickets. In: Seminars in nephrology; Amsterdam: Elsevier. 1992."},{"issue":"3","key":"3220_CR9","first-page":"1871","volume":"7","author":"R Kumar","year":"2015","unstructured":"Kumar R, Folpe AL, Mullan BP. Tumor-induced osteomalacia. Transl Endocrinol Metab. 2015;7(3):1871.","journal-title":"Transl Endocrinol Metab"},{"key":"3220_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/978-1-4613-4217-5_44","volume-title":"Phosphate metabolism","author":"M Peacock","year":"1977","unstructured":"Peacock M, et\u00a0al. The action of 1\u03b1hydroxy vitamin D 3 and phosphate supplements in hypophosphataemic osteomalacia. In: Phosphate metabolism. Springer; 1977. p. 431\u201340."},{"issue":"4","key":"3220_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.afos.2018.12.001","volume":"4","author":"Z Yin","year":"2018","unstructured":"Yin Z, et\u00a0al. Tumor-induced osteomalacia. Osteoporos Sarcopenia. 2018;4(4):119\u201327.","journal-title":"Osteoporos Sarcopenia"},{"issue":"8","key":"3220_CR12","doi-asserted-by":"publisher","first-page":"e10374","DOI":"10.1002\/jbm4.10374","volume":"4","author":"T Cundy","year":"2020","unstructured":"Cundy T, et\u00a0al. Bisphosphonate-induced deterioration of osteomalacia in undiagnosed adult Fanconi syndrome. JBMR Plus. 2020;4(8):e10374.","journal-title":"JBMR Plus"},{"issue":"1","key":"3220_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/BPB.0b013e32832f59cb","volume":"19","author":"G-H Jung","year":"2010","unstructured":"Jung G-H, et\u00a0al. A 9-month-old phosphaturic mesenchymal tumor mimicking the intractable rickets. J Pediatric Orthop B. 2010;19(1):127\u201332.","journal-title":"J Pediatric Orthop B"},{"key":"3220_CR14","doi-asserted-by":"crossref","unstructured":"Feng J, et\u00a0al. The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases. Endocrine J. 2017; EJ16-0587.","DOI":"10.1507\/endocrj.EJ16-0587"},{"issue":"2","key":"3220_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1210\/jcem.86.2.7408","volume":"86","author":"KE White","year":"2001","unstructured":"White KE, et\u00a0al. The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab. 2001;86(2):497\u2013500.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3220_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1530\/EC-18-0552","volume":"8","author":"R Pal","year":"2019","unstructured":"Pal R, et\u00a0al. Tumor-induced osteomalacia: experience from three tertiary care centers in India. Endocr Connect. 2019;8(3):266\u201376.","journal-title":"Endocr Connect"},{"key":"3220_CR17","first-page":"1","volume":"2017","author":"S Beygi","year":"2017","unstructured":"Beygi S, Denio A, Sharma TS. The foot that broke both hips: a case report and literature review of tumor-induced osteomalacia. Case Rep Rheumatol. 2017;2017:1.","journal-title":"Case Rep Rheumatol"},{"issue":"3","key":"3220_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/81664","volume":"26","author":"KE White","year":"2000","unstructured":"White KE, et\u00a0al. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet. 2000;26(3):345\u20138.","journal-title":"Nat Genet"},{"issue":"1","key":"3220_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00424-018-2184-2","volume":"471","author":"C Bergwitz","year":"2019","unstructured":"Bergwitz C, Miyamoto K-I. Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy. Pfl\u00fcgers Archiv-Eur J Physiol. 2019;471(1):149\u201363.","journal-title":"Pfl\u00fcgers Archiv-Eur J Physiol"},{"issue":"3\u20135","key":"3220_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jsbmb.2006.11.010","volume":"103","author":"S Sommer","year":"2007","unstructured":"Sommer S, et\u00a0al. The phosphatonins and the regulation of phosphate transport and vitamin D metabolism. J Steroid Biochem Mol Biol. 2007;103(3\u20135):497\u2013503.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3220_CR21","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Lamu\u00f1o, D., Hypophosphataemic rickets: diagnosis algorithm\u2014how not to make a mistake. Adv Therapy. 2020; 1\u201310.","DOI":"10.1007\/s12325-019-01184-1"},{"issue":"7120","key":"3220_CR22","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa I, et\u00a0al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006;444(7120):770\u20134.","journal-title":"Nature"},{"issue":"3","key":"3220_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, et\u00a0al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res. 2004;19(3):429\u201335.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"3220_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1053\/j.ackd.2010.11.004","volume":"18","author":"Y Sabbagh","year":"2011","unstructured":"Sabbagh Y, et\u00a0al. Intestinal phosphate transport. Adv Chronic Kidney Dis. 2011;18(2):85\u201390.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"11","key":"3220_CR25","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1210\/jc.2002-021105","volume":"87","author":"Y Yamazaki","year":"2002","unstructured":"Yamazaki Y, et\u00a0al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. J Clin Endocrinol Metab. 2002;87(11):4957\u201360.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"3220_CR26","first-page":"1922","volume":"56","author":"JC Reubi","year":"1996","unstructured":"Reubi JC, et\u00a0al. Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification. Can Res. 1996;56(8):1922\u201331.","journal-title":"Can Res"},{"issue":"10","key":"3220_CR27","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1210\/jc.2016-2052","volume":"101","author":"D El-Maouche","year":"2016","unstructured":"El-Maouche D, et\u00a0al. 68Ga-DOTATATE for tumor localization in tumor-induced osteomalacia. J Clin Endocrinol Metab. 2016;101(10):3575\u201381.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3220_CR28","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1530\/EJE-07-0779","volume":"158","author":"G van Boekel","year":"2008","unstructured":"van Boekel G, et\u00a0al. Tumor producing fibroblast growth factor 23 localized by two-staged venous sampling. Eur J Endocrinol. 2008;158(3):431\u20138.","journal-title":"Eur J Endocrinol"},{"issue":"26","key":"3220_CR29","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa010839","volume":"345","author":"J Seufert","year":"2001","unstructured":"Seufert J, et\u00a0al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med. 2001;345(26):1883\u20138.","journal-title":"N Engl J Med"},{"issue":"2","key":"3220_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s00774-012-0384-y","volume":"31","author":"DH Kim","year":"2013","unstructured":"Kim DH, Sung DH, Min YK. Hypophosphatemic osteomalacia induced by low-dose adefovir therapy: focus on manifestations in the skeletal system and literature review. J Bone Miner Metab. 2013;31(2):240\u20136.","journal-title":"J Bone Miner Metab"},{"issue":"8","key":"3220_CR31","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/jbmr.3162","volume":"32","author":"D Ovejero","year":"2017","unstructured":"Ovejero D, et\u00a0al. Octreotide is ineffective in treating tumor-induced osteomalacia: results of a short-term therapy. J Bone Miner Res. 2017;32(8):1667\u201371.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"3220_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00223-010-9369-9","volume":"86","author":"A Ishii","year":"2010","unstructured":"Ishii A, et\u00a0al. The levels of somatostatin receptors in causative tumors of oncogenic osteomalacia are insufficient for their agonist to normalize serum phosphate levels. Calcif Tissue Int. 2010;86(6):455\u201362.","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"3220_CR33","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00223-015-0029-y","volume":"98","author":"S Fukumoto","year":"2016","unstructured":"Fukumoto S. FGF23-FGF receptor\/Klotho pathway as a new drug target for disorders of bone and mineral metabolism. Calcif Tissue Int. 2016;98(4):334\u201340.","journal-title":"Calcif Tissue Int"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-03220-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-03220-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-03220-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:03:19Z","timestamp":1641945799000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-03220-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3220"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-03220-7","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,12]]},"assertion":[{"value":"28 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The faculty of Health Sciences, Human Research and Ethics Committee University of Cape Town waives the need for ethics approval for case studies, but individual patient consent is required for publication. Patient consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We have no conflict of interest, whatsoever.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}